Lilly reports its weight-loss drug boosted how well the psoriasis treatment Taltz worked when the two were given together.
Recap by typeshit. Full story at MedWatch.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Sehar Shahid explains how she runs a weight loss clinic out of her internet pharmacy, 24-hour Pharmacy. Few other details are given.
Australia's weight loss market could change as an oral GLP-1 pill moves closer to regulatory approval, 7NEWS Adelaide reports. Few details given so far.
Loading…